Xenon Pharmaceuticals (XENE) Superinvestor holders
15 of the superinvestors we track hold Xenon Pharmaceuticals (XENE) in their latest 13F filings, $288M in total.
Summary
The largest holder is Two Sigma (Two Sigma Investments), with $99M, 0.1% of the portfolio.
In their latest quarter: 4 opened a new position, 4 added, 5 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Two Sigma Two Sigma Investments |
Added | 1,642,848 | $99M | 0.1% | Q2 2026 |
| Paul Marshall Marshall Wace |
New position | 689,342 | $42M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Added | 545,387 | $33M | 0.1% | Q2 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Trimmed | 527,273 | $32M | 0.0% | Q2 2026 |
| Man Group Man Group plc |
New position | 310,617 | $19M | 0.0% | Q2 2026 |
| Stanley Druckenmiller Duquesne Family Office |
Held | 238,600 | $14M | 0.3% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 223,922 | $14M | 0.0% | Q2 2026 |
| Jennison Associates | Trimmed | 208,060 | $13M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 187,110 | $11M | 0.0% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
New position | 130,378 | $8M | 0.0% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Held | 25,000 | $2M | 0.0% | Q2 2026 |
| Alec Litowitz Magnetar Capital |
New position | 18,213 | $1M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Trimmed | 9,945 | $600,280 | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | 7,263 | $438,394 | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 5,394 | $325,582 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 16 |
| Q1 2026 | 13 |
| Q4 2025 | 12 |
| Q3 2025 | 11 |
| Q2 2025 | 10 |
| Q1 2025 | 10 |
| Q4 2024 | 12 |
| Q3 2024 | 12 |
Questions about Xenon Pharmaceuticals
Which superinvestors own Xenon Pharmaceuticals?
15 of the superinvestors we track hold Xenon Pharmaceuticals (XENE) in their latest 13F filings, $288M in total. Two Sigma, Paul Marshall, Paul Tudor Jones, Aziz Hamzaogullari, Man Group, Stanley Druckenmiller.
Who is the largest superinvestor holder of XENE?
The largest holder is Two Sigma (Two Sigma Investments), with $99M, 0.1% of the portfolio.
From Xenon Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.